Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 2
2016 2
2017 1
2018 3
2019 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Mutational Epidemiology of Congenital Fibrinogen Disorders.
Casini A, Blondon M, Tintillier V, Goodyer M, Sezgin ME, Gunes AM, Hanss M, de Moerloose P, Neerman-Arbez M. Casini A, et al. Among authors: tintillier v. Thromb Haemost. 2018 Nov;118(11):1867-1874. doi: 10.1055/s-0038-1673685. Epub 2018 Oct 17. Thromb Haemost. 2018. PMID: 30332696
Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A.
Saultier P, Guillaume Y, Demiguel V, Berger C, Borel-Derlon A, Claeyssens S, Harroche A, Oudot C, Rafowicz A, Trossaert M, Wibaut B, Vinciguerra C, Boucekine M, Baumstarck K, Meunier S, Calvez T, Chambost H; FranceCoag PUPs / CoMETH Prophylaxis Study Group; Hemophilia Treatment Centers of Paris-Necker. Saultier P, et al. J Pediatr. 2021 Jul;234:212-219.e3. doi: 10.1016/j.jpeds.2021.02.071. Epub 2021 Mar 4. J Pediatr. 2021. PMID: 33676933 Clinical Trial.
Natural history of patients with congenital dysfibrinogenemia.
Casini A, Blondon M, Lebreton A, Koegel J, Tintillier V, de Maistre E, Gautier P, Biron C, Neerman-Arbez M, de Moerloose P. Casini A, et al. Among authors: tintillier v. Blood. 2015 Jan 15;125(3):553-61. doi: 10.1182/blood-2014-06-582866. Epub 2014 Oct 15. Blood. 2015. PMID: 25320241 Free PMC article.
Fibrin clot structure in patients with congenital dysfibrinogenaemia.
Casini A, Duval C, Pan X, Tintillier V, Biron-Andreani C, Ariëns RAS. Casini A, et al. Among authors: tintillier v. Thromb Res. 2016 Jan;137:189-195. doi: 10.1016/j.thromres.2015.11.008. Epub 2015 Nov 10. Thromb Res. 2016. PMID: 26577257 Free article.
Microparticle phenotypes are associated with driver mutations and distinct thrombotic risks in essential thrombocythemia.
Charpentier A, Lebreton A, Rauch A, Bauters A, Trillot N, Nibourel O, Tintillier V, Wemeau M, Demory JL, Preudhomme C, Jude B, Lecompte T, Cambier N, Susen S. Charpentier A, et al. Among authors: tintillier v. Haematologica. 2016 Sep;101(9):e365-8. doi: 10.3324/haematol.2016.144279. Epub 2016 May 31. Haematologica. 2016. PMID: 27247323 Free PMC article. No abstract available.
FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders.
Doncarli A, Demiguel V, Guseva Canu I, Goulet V, Bayart S, Calvez T, Castet S, Dalibard V, Demay Y, Frotscher B, Goudemand J, Lambert T, Milien V, Oudot C, Sannié T, Chambost H; FranceCoag Network. Doncarli A, et al. Eur J Epidemiol. 2019 May;34(5):521-532. doi: 10.1007/s10654-018-0468-7. Epub 2018 Dec 5. Eur J Epidemiol. 2019. PMID: 30515664
Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A.
Calvez T, Chambost H, d'Oiron R, Dalibard V, Demiguel V, Doncarli A, Gruel Y, Huguenin Y, Lutz P, Rothschild C, Vinciguerra C, Goudemand J; for FranceCoag Collaborators. Calvez T, et al. Haematologica. 2018 Jan;103(1):179-189. doi: 10.3324/haematol.2017.174706. Epub 2017 Oct 12. Haematologica. 2018. PMID: 29025913 Free PMC article.